RecoveryInvestigational

Sinapultide (KL4 Surfactant)

Intratracheal instillation

Overview

Sinapultide is a synthetic 21-amino acid peptide that mimics the structure and function of surfactant protein B, a critical component of pulmonary surfactant. When combined with phospholipids, sinapultide forms a surface-active complex that reduces alveolar surface tension, improving gas exchange and lung compliance.

Mechanism of Action

It has been investigated primarily for treatment of acute respiratory distress syndrome and neonatal respiratory distress..

Research Summary & Key Findings

Phase II trials in acute lung injury and ARDS populations demonstrated trends toward improved oxygenation but did not meet primary efficacy endpoints for mortality reduction in larger phase III studies. Development was discontinued by the sponsor after results from multicenter trials failed to show significant clinical benefit.

Clinical Status

Investigational

Sinapultide (KL4 Surfactant) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Intratracheal instillation

Related Peptides in Recovery

Find a Provider

Find a verified provider who offers Sinapultide (KL4 Surfactant) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Sinapultide (KL4 Surfactant).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.